Berenberg Bank set a €42.00 ($48.84) price target on Siemens Healthineers (ETR:SHL) in a research report report published on Thursday morning, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.
Several other brokerages have also weighed in on SHL. HSBC set a €42.00 ($48.84) target price on Siemens Healthineers and gave the stock a buy rating in a research report on Wednesday, January 23rd. UBS Group set a €36.00 ($41.86) price objective on Siemens Healthineers and gave the company a neutral rating in a report on Thursday, May 2nd. Goldman Sachs Group set a €34.00 ($39.53) price objective on Siemens Healthineers and gave the company a neutral rating in a report on Wednesday, January 16th. Jefferies Financial Group set a €38.00 ($44.19) price objective on Siemens Healthineers and gave the company a neutral rating in a report on Friday, May 3rd. Finally, JPMorgan Chase & Co. set a €34.40 ($40.00) price objective on Siemens Healthineers and gave the company a neutral rating in a report on Wednesday, January 16th. Thirteen research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The company presently has a consensus rating of Hold and an average price target of €38.15 ($44.36).
Shares of SHL stock opened at €36.30 ($42.21) on Thursday. The company has a current ratio of 1.44, a quick ratio of 0.97 and a debt-to-equity ratio of 46.72. Siemens Healthineers has a fifty-two week low of €31.90 ($37.09) and a fifty-two week high of €39.95 ($46.45). The stock has a market capitalization of $36.28 billion and a price-to-earnings ratio of 28.14.
Siemens Healthineers Company Profile
Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.
Featured Article: How are institutional investors different from individual investors?
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.